应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06622 兆科眼科-B
已收盘 12-15 15:59:25
3.100
-0.010
-0.32%
最高
3.130
最低
3.080
成交量
25.00万
今开
3.100
昨收
3.110
日振幅
1.61%
总市值
16.99亿
流通市值
16.99亿
总股本
5.48亿
成交额
77.55万
换手率
0.05%
流通股本
5.48亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
李氏大药厂12月12日主力净流入36.4万元 散户资金抛售
市场透视 · 12-12
李氏大药厂12月12日主力净流入36.4万元 散户资金抛售
兆科眼科-B12月11日主力净流出173.3万元 散户资金买入
市场透视 · 12-11
兆科眼科-B12月11日主力净流出173.3万元 散户资金买入
兆科眼科-B12月09日主力净流出34.1万元 散户资金买入
市场透视 · 12-09
兆科眼科-B12月09日主力净流出34.1万元 散户资金买入
李氏大药厂(00950):附属拟1500万美元收购Alexza Pharmaceuticals, Inc.与Alexza业务有关的所购资产
智通财经 · 12-09
李氏大药厂(00950):附属拟1500万美元收购Alexza Pharmaceuticals, Inc.与Alexza业务有关的所购资产
兆科眼科-B(06622)拟与东生华制药于台湾地区共同推进BRIMOCHOL™PF的临床导论及未来商业化
智通财经 · 12-08
兆科眼科-B(06622)拟与东生华制药于台湾地区共同推进BRIMOCHOL™PF的临床导论及未来商业化
兆科眼科-B与Tsh Biopharm获得在台湾的Brimcholtm Pf独家分销权
美股速递 · 12-08
兆科眼科-B与Tsh Biopharm获得在台湾的Brimcholtm Pf独家分销权
李氏大药厂12月05日主力净流出16.9万元 散户资金买入
市场透视 · 12-05
李氏大药厂12月05日主力净流出16.9万元 散户资金买入
兆科眼科-B12月04日遭主力抛售57.6万元
市场透视 · 12-04
兆科眼科-B12月04日遭主力抛售57.6万元
兆科眼科-B12月01日主力净流出22.4万元 散户资金买入
市场透视 · 12-01
兆科眼科-B12月01日主力净流出22.4万元 散户资金买入
李氏大药厂11月26日遭主力抛售33.6万元
市场透视 · 11-26
李氏大药厂11月26日遭主力抛售33.6万元
兆科眼科-B(06622):国家药监局批准PAN-90806的新药临床试验申请及盐酸依匹斯汀滴眼液取得国家药监局的上市批准
智通财经 · 11-24
兆科眼科-B(06622):国家药监局批准PAN-90806的新药临床试验申请及盐酸依匹斯汀滴眼液取得国家药监局的上市批准
兆科眼科-B11月24日主力净流出3.0万元 散户资金买入
市场透视 · 11-24
兆科眼科-B11月24日主力净流出3.0万元 散户资金买入
兆科眼科-B盘中异动 临近午盘股价大跌5.17%
市场透视 · 11-18
兆科眼科-B盘中异动 临近午盘股价大跌5.17%
李氏大药厂11月14日主力净流出28.2万元 散户资金买入
市场透视 · 11-14
李氏大药厂11月14日主力净流出28.2万元 散户资金买入
兆科眼科-B11月12日遭主力抛售28.3万元
市场透视 · 11-12
兆科眼科-B11月12日遭主力抛售28.3万元
兆科眼科前首席医学官蔡建明加入维眸生物
第一财经 · 11-12
兆科眼科前首席医学官蔡建明加入维眸生物
兆科眼科-B(06622.HK)涨近10%
每日经济新闻 · 11-10
兆科眼科-B(06622.HK)涨近10%
港股异动 | 兆科眼科-B(06622)涨近10% 近期与印尼药企PT Ferron就分销老花眼药达成协议
智通财经网 · 11-10
港股异动 | 兆科眼科-B(06622)涨近10% 近期与印尼药企PT Ferron就分销老花眼药达成协议
兆科眼科-B盘中异动 大幅上涨5.64%报3.560港元
市场透视 · 11-10
兆科眼科-B盘中异动 大幅上涨5.64%报3.560港元
兆科眼科-B(06622)就于印度尼西亚商业化BRIMOCHOL™ PF与PT FERRON订立分销协议
智通财经 · 11-06
兆科眼科-B(06622)就于印度尼西亚商业化BRIMOCHOL™ PF与PT FERRON订立分销协议
暂无数据
公司概况
公司名称:
兆科眼科-B
所属市场:
SEHK
上市日期:
--
主营业务:
兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司已建立创新药及仿制药组合,针对影响眼前节及眼后节的六种主要眼科疾病。该等主要眼科适应症为干眼症(DED)、近视、老花眼、湿性老年黄斑部病变(wAMD)/糖尿病黄斑水肿(DME)、青光眼及角膜上皮功能障碍(CED)。该公司的主要产品管线包括NVK002(阿托品)、环孢素A眼凝胶、TAB014(贝伐单抗)等。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06622","market":"HK","secType":"STK","nameCN":"兆科眼科-B","latestPrice":3.1,"timestamp":1765785565408,"preClose":3.11,"halted":0,"volume":250000,"delay":0,"floatShares":548000000,"shares":548000000,"eps":-0.48061115299610896,"marketStatus":"已收盘","change":-0.01,"latestTime":"12-15 15:59:25","open":3.1,"high":3.13,"low":3.08,"amount":775485,"amplitude":0.016077,"askPrice":3.13,"askSize":5500,"bidPrice":3.1,"bidSize":97500,"shortable":0,"etf":0,"ttmEps":-0.5632192687937743,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"listingDate":1619625600000,"exchange":"SEHK","adjPreClose":3.11,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":0.410172,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06622/tweets","defaultTab":"tweets","newsList":[{"id":"2590572669","title":"李氏大药厂12月12日主力净流入36.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590572669","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590572669?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527337,"startTime":"0","endTime":"0","summary":"12月12日, 李氏大药厂股价涨4.32%,报收1.69元,成交金额140.7万元,换手率0.14%,振幅4.32%,量比1.28。李氏大药厂今日主力资金净流入36.4万元,上一交易日主力净流出0万元。该股近5个交易日上涨0.60%,主力资金累计净流出49.6万元;近20日主力资金累计净流出212.1万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162422979e8aba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162422979e8aba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","06622","BK1587","BK1574","00950"],"gpt_icon":0},{"id":"2590284745","title":"兆科眼科-B12月11日主力净流出173.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590284745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590284745?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440946,"startTime":"0","endTime":"0","summary":"12月11日, 兆科眼科-B股价跌2.24%,报收3.05元,成交金额510.8万元,换手率0.30%,振幅2.88%,量比4.36。兆科眼科-B今日主力资金净流出173.3万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.56%,主力资金累计净流出207.4万元;近20日主力资金累计净流出208.0万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121116200695375525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121116200695375525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06622","BK1587","BK1583"],"gpt_icon":0},{"id":"2590834329","title":"兆科眼科-B12月09日主力净流出34.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590834329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590834329?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:15","pubTimestamp":1765268132,"startTime":"0","endTime":"0","summary":"12月09日, 兆科眼科-B股价跌0.32%,报收3.13元,成交金额185.4万元,换手率0.11%,振幅3.82%,量比1.55。兆科眼科-B今日主力资金净流出34.1万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.19%,主力资金累计净流出139.2万元;近20日主力资金累计净流出158.9万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209161750a72ce7bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209161750a72ce7bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06622","BK1574","BK1587","BK1583"],"gpt_icon":0},{"id":"2590943369","title":"李氏大药厂(00950):附属拟1500万美元收购Alexza Pharmaceuticals, Inc.与Alexza业务有关的所购资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2590943369","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590943369?lang=zh_cn&edition=full","pubTime":"2025-12-09 06:10","pubTimestamp":1765231835,"startTime":"0","endTime":"0","summary":"智通财经APP讯,李氏大药厂 发布公告,于2025年12月8日,买方Nova Pneuma Incorporated、本公司、卖方Alexza Pharmaceuticals, Inc.及卖方母公司Grupo Ferrer International, S.A.,订立资产购买协议,据此,买方同意收购而卖方同意出售与Alexza业务有关的所购资产,代价为1500万美元。所购资产包含所有与Alexza业务相关的资产、物业、设备及机械、物料、专利及其他知识产权、技术知识、权利及已转让合约。收购所购资产符合本集团透过《Staccato》平台扩大创新给药技术产品组合的策略,并与本公司的全球拓展策略相符。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","00950","BK1191","06622","BK1574","BK1583"],"gpt_icon":0},{"id":"2589533373","title":"兆科眼科-B(06622)拟与东生华制药于台湾地区共同推进BRIMOCHOL™PF的临床导论及未来商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2589533373","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589533373?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:48","pubTimestamp":1765183700,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B 公布,公司与以台湾为基地的东生华制药股份有限公司订立策略性伙伴关系,于台湾地区共同推进BRIMOCHOL PF的临床导论及未来商业化。东生华制药精于慢性病及精准医疗,提供安全而易于获取的照护解决方案。根据协议条款,兆科授予东生华制药以独家分销商身份于台湾地区注册、进口、推广、分销、营销及销售BRIMOCHOL PF的权利。于2025年6月,兆科的伙伴兼BRIMOCHOL PF的开发商Tenpoint Therapeutics, Ltd.宣布,美国FDA已受理该药品的新药上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1587","01477","06622","BK1191","BK1574"],"gpt_icon":0},{"id":"1122548376","title":"兆科眼科-B与Tsh Biopharm获得在台湾的Brimcholtm Pf独家分销权","url":"https://stock-news.laohu8.com/highlight/detail?id=1122548376","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122548376?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:48","pubTimestamp":1765183689,"startTime":"0","endTime":"0","summary":"兆科眼科-B与Tsh Biopharm获得在台湾的Brimcholtm Pf独家分销权","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","BK1587","BK1583","06622"],"gpt_icon":0},{"id":"2589896977","title":"李氏大药厂12月05日主力净流出16.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2589896977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589896977?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922542,"startTime":"0","endTime":"0","summary":"12月05日, 李氏大药厂股价跌0.59%,报收1.68元,成交金额58.0万元,换手率0.06%,振幅2.37%,量比0.46。李氏大药厂今日主力资金净流出16.9万元,上一交易日主力净流出0万元。该股主力净额占比0.02%,港股市场排名2512/2689。|12月05日主力加仓幅度排名||#|股票简称|主力净额占比|#|信能低碳|3.88%|#|万励达|2.38%|#|易和国际控股|2.18%|#|...|...|#2513|李氏大药厂|-0.02%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161909952c6ba3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161909952c6ba3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","BK1574","00950","BK1191","06622"],"gpt_icon":0},{"id":"2589186594","title":"兆科眼科-B12月04日遭主力抛售57.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589186594","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589186594?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836159,"startTime":"0","endTime":"0","summary":"12月04日, 兆科眼科-B股价跌0.32%,报收3.13元,成交金额197.6万元,换手率0.12%,振幅2.87%,量比0.97。兆科眼科-B今日主力资金净流出57.6万元,上一交易日主力净流出47.6万元。该股近5个交易日下跌4.28%,主力资金累计净流出127.6万元;近20日主力资金累计净流出279.2万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162206a4cc303b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162206a4cc303b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1587","06622","BK1574"],"gpt_icon":0},{"id":"2588570703","title":"兆科眼科-B12月01日主力净流出22.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588570703","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588570703?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576921,"startTime":"0","endTime":"0","summary":"12月01日, 兆科眼科-B股价跌3.87%,报收3.23元,成交金额369.5万元,换手率0.21%,振幅6.25%,量比1.36。兆科眼科-B今日主力资金净流出22.4万元,上一交易日主力净流出0万元。该股近5个交易日上涨5.56%,主力资金累计净流出22.4万元;近20日主力资金累计净流出86.8万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116160995243dd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116160995243dd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","06622","BK1191","BK1583"],"gpt_icon":0},{"id":"2586226378","title":"李氏大药厂11月26日遭主力抛售33.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586226378","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586226378?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:16","pubTimestamp":1764144962,"startTime":"0","endTime":"0","summary":"11月26日, 李氏大药厂股价跌2.33%,报收1.68元,成交金额299.5万元,换手率0.30%,振幅5.23%,量比1.87。李氏大药厂今日主力资金净流出33.6万元,上一交易日主力净流出41.9万元。该股近5个交易日下跌7.18%,主力资金累计净流出101.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出282.5万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126162308951b45d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126162308951b45d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","06622","00950","BK1191","BK1574","BK1583"],"gpt_icon":0},{"id":"2585457376","title":"兆科眼科-B(06622):国家药监局批准PAN-90806的新药临床试验申请及盐酸依匹斯汀滴眼液取得国家药监局的上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2585457376","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585457376?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:00","pubTimestamp":1763974816,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B 发布公告,于2025年11月18日,中国国家药品监督管理局已批准本公司就PAN-90806滴眼液用于治疗湿性老年黄斑部病变作出的新药临床试验申请。另一发展方面,董事会欣然宣布,于2025年11月19日,本公司就针对过敏性结膜炎的盐酸依匹斯汀滴眼液取得国家药监局的上市批准。预期使用PAN-90806将大幅减少治疗中断的情况,从而通过提升患者舒适性、接受性、便捷性及遵医嘱性减缓相关疾病恶化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"2586117442","title":"兆科眼科-B11月24日主力净流出3.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586117442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586117442?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:15","pubTimestamp":1763972105,"startTime":"0","endTime":"0","summary":"11月24日, 兆科眼科-B股价跌1.29%,报收3.06元,成交金额295.4万元,换手率0.18%,振幅3.23%,量比1.00。兆科眼科-B今日主力资金净流出3.0万元,上一交易日主力净流出0万元。该股近5个交易日下跌12.07%,主力资金累计净流入101.3万元;近20日主力资金累计净流出114.6万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161511a4b6992c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161511a4b6992c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1587","BK1574","06622"],"gpt_icon":0},{"id":"2584988639","title":"兆科眼科-B盘中异动 临近午盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584988639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584988639?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:52","pubTimestamp":1763437974,"startTime":"0","endTime":"0","summary":"2025年11月18日临近午盘11时52分,兆科眼科-B股票出现波动,股价急速下挫5.17%。截至发稿,该股报3.300港元/股,成交量71.6万股,换手率0.13%,振幅4.31%。兆科眼科-B股票所在的药品行业中,整体跌幅为0.06%。兆科眼科-B公司简介:兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118115254a4a92cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118115254a4a92cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06622","BK1574","BK1587","BK1583"],"gpt_icon":0},{"id":"2583689981","title":"李氏大药厂11月14日主力净流出28.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2583689981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583689981?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:16","pubTimestamp":1763108162,"startTime":"0","endTime":"0","summary":"11月14日, 李氏大药厂股价跌3.17%,报收1.83元,成交金额157.2万元,换手率0.14%,振幅3.17%,量比0.98。李氏大药厂今日主力资金净流出28.2万元,上一交易日主力净流出0万元。该股近5个交易日上涨1.67%,主力资金累计净流出28.2万元;近20日主力资金累计净流入10.7万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141624159504169e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141624159504169e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1574","BK1191","06622","BK1587","BK1583"],"gpt_icon":0},{"id":"2583307247","title":"兆科眼科-B11月12日遭主力抛售28.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583307247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583307247?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:15","pubTimestamp":1762935347,"startTime":"0","endTime":"0","summary":"11月12日, 兆科眼科-B股价跌1.88%,报收3.65元,成交金额789.3万元,换手率0.39%,振幅4.03%,量比1.21。兆科眼科-B今日主力资金净流出28.3万元,上一交易日主力净流出218.1万元。该股近5个交易日上涨19.28%,主力资金累计净流出133.6万元;近20日主力资金累计净流出1.6万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111216205497644ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111216205497644ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1587","BK1574","BK1583","06622"],"gpt_icon":0},{"id":"2582310378","title":"兆科眼科前首席医学官蔡建明加入维眸生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2582310378","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582310378?lang=zh_cn&edition=full","pubTime":"2025-11-12 10:32","pubTimestamp":1762914775,"startTime":"0","endTime":"0","summary":"【兆科眼科前首席医学官蔡建明加入维眸生物】11月12日,维眸生物科技(浙江)有限公司宣布任命蔡建明为首席医学官。蔡建明将全面领导临床及医学团队,负责产品管线战略、临床项目的规划与运营,以及参与规划公司的整体发展策略。在加入维眸之前,蔡建明曾在多家全球性医药企业担任高管并领导临床团队,曾任兆科眼科CMO、PPD Inc.亚太区副总裁及医学总监、MDCO亚太区副总裁。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://hk.eastmoney.com/a/202511123562006295.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202511123562006295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1191","BK1587","06622","BK1574"],"gpt_icon":0},{"id":"2582984373","title":"兆科眼科-B(06622.HK)涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582984373","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582984373?lang=zh_cn&edition=full","pubTime":"2025-11-10 11:28","pubTimestamp":1762745299,"startTime":"0","endTime":"0","summary":"每经AI快讯,兆科眼科-B(06622.HK)涨近10%,截至发稿,涨9.79%,报3.7元,成交额655.18万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511103559616917.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511103559616917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1574","BK1583","BK1587","06622"],"gpt_icon":0},{"id":"2582184872","title":"港股异动 | 兆科眼科-B(06622)涨近10% 近期与印尼药企PT Ferron就分销老花眼药达成协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2582184872","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582184872?lang=zh_cn&edition=full","pubTime":"2025-11-10 11:07","pubTimestamp":1762744044,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,兆科眼科-B涨近10%,截至发稿,涨9.79%,报3.7元,成交额655.18万港元。消息面上,11月6日晚,兆科眼科宣布,公司已与印度尼西亚领先制药公司PT Ferron Par Pharmaceuticals,就公司核心产品之一、用于治疗老花眼的创新药物BRIMOCHOL PF,签订了一份针对印度尼西亚市场的分销和供应协议。根据协议条款,兆科眼科授予PT Ferron在印度尼西亚进口、推广、分销、营销和销售该产品的独家权利。兆科眼科将获得一笔预付款项,并可根据若干成就获得额外的里程碑付款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["PT","06622","BK4166","BK1583","BK1574","BK1191","BK1587"],"gpt_icon":0},{"id":"2582172648","title":"兆科眼科-B盘中异动 大幅上涨5.64%报3.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582172648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582172648?lang=zh_cn&edition=full","pubTime":"2025-11-10 09:39","pubTimestamp":1762738769,"startTime":"0","endTime":"0","summary":"2025年11月10日早盘09时39分,兆科眼科-B股票出现异动,股价急速拉升5.64%。截至发稿,该股报3.560港元/股,成交量38.65万股,换手率0.07%,振幅5.34%。资金方面,该股资金流入99.429万港元,流出24.8825万港元。兆科眼科-B股票所在的药品行业中,整体涨幅为0.01%。其相关个股中,劲方医药-B、兆科眼科-B、君圣泰医药-B涨幅较大,振幅较大的相关个股有劲方医药-B、兆科眼科-B、三生制药,振幅分别为11.93%、5.34%、4.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111009392994fa3db7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111009392994fa3db7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1583","BK1574","BK1191","BK1587"],"gpt_icon":0},{"id":"2581050003","title":"兆科眼科-B(06622)就于印度尼西亚商业化BRIMOCHOL™ PF与PT FERRON订立分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2581050003","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581050003?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:47","pubTimestamp":1762422456,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B 发布公告,公司与领先印度尼西亚制药公司PT Ferron Par Pharmaceuticals就于印度尼西亚商业化BRIMOCHOL PF订立分销及供应协议。于2025年6月,BRIMOCHOL PF的开发商Tenpoint宣布,美国FDA已受理该药品的新药上市申请。FDA已就BRIMOCHOL PF制定处方药使用者付费法案,审核截止日期为2026年1月28日。BRIMOCHOL PF为一款不含防腐剂、每日一次实验性滴眼液,用于矫正因老化丧失近距离视力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1583","BK1587","BK4166","PT","BK1191","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.1479},{"period":"3month","weight":-0.2206},{"period":"6month","weight":0.0471},{"period":"1year","weight":1.3209},{"period":"ytd","weight":1.5917}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司已建立创新药及仿制药组合,针对影响眼前节及眼后节的六种主要眼科疾病。该等主要眼科适应症为干眼症(DED)、近视、老花眼、湿性老年黄斑部病变(wAMD)/糖尿病黄斑水肿(DME)、青光眼及角膜上皮功能障碍(CED)。该公司的主要产品管线包括NVK002(阿托品)、环孢素A眼凝胶、TAB014(贝伐单抗)等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.123174},{"month":2,"riseRate":0.25,"avgChangeRate":-0.139199},{"month":3,"riseRate":0.25,"avgChangeRate":-0.026625},{"month":4,"riseRate":0.25,"avgChangeRate":0.028543},{"month":5,"riseRate":0.4,"avgChangeRate":0.043975},{"month":6,"riseRate":0.2,"avgChangeRate":0.042663},{"month":7,"riseRate":0.4,"avgChangeRate":-0.054975},{"month":8,"riseRate":0.2,"avgChangeRate":-0.017626},{"month":9,"riseRate":0.6,"avgChangeRate":0.007418},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082811},{"month":11,"riseRate":0.4,"avgChangeRate":0.029799},{"month":12,"riseRate":0.2,"avgChangeRate":-0.009185}],"exchange":"SEHK","name":"兆科眼科-B","nameEN":"ZHAOKE OPHTH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兆科眼科-B,06622,兆科眼科-B股票,兆科眼科-B股票老虎,兆科眼科-B股票老虎国际,兆科眼科-B行情,兆科眼科-B股票行情,兆科眼科-B股价,兆科眼科-B股市,兆科眼科-B股票价格,兆科眼科-B股票交易,兆科眼科-B股票购买,兆科眼科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}